Royalty Pharma Reports Q4 and Full Year 2024 Results
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...
Royalty Pharma plc: Royalty Pharma Reports Q4 and Full Year 2024 Results
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...
manilatimes28d
FDA set to reduce drug registration timeline
During an interview at state-run PTV-4's "Bagong Pilipinas Ngayon," FDA Director-General Samuel Zacate said that they aim to revise Department of Health Administrative Order 67 series of 1989, which ...
CNN4d
FDA’s plan to propose ban on formaldehyde in hair-straightening products remains in limbo under Trump administration
Due to concerns about these chemicals’ links to cancer risks, the FDA under the Biden administration considered proposing a ban on these ingredients in certain cosmetic products such as chemical ...
Popular Science24d
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
Dallas Innovates1d
How a Former Neiman Marcus Exec Made Goodwill Dallas the Fastest-Growing Goodwill in North America
Tim Heis left the high-end luxe world of Neiman Marcus for a scattered collection of North Texas Goodwill thrift stores. He ...
UVA Today25d
FDA Bans Red Dye No. 3 in Food, Decades After Banning It in Cosmetics
Red 3, also known as erythrosine or FD&C Red No. 3, is a red synthetic food dye used to give certain drinks, cough syrups and foods “a bright, cherry color,” according to the FDA. The agency’s report ...
ABC News29d
RFK Jr. petitioned FDA in 2021 to revoke authorization of all COVID vaccines
MORE: RFK Jr. meets with more GOP senators amid concerns about his polio vaccine views It came five months after then-President Donald Trump proudly announced the FDA's green light of the vaccine ...
Newsweek24d
FDA Approves Nasal Spray for Depression
However, it had to be used in conjunction with an oral medication. The FDA has now expanded its approval to include the standalone use of the nasal spray for adults with treatment-resistant major ...
UPI24d
FDA approves Spravato, first monotherapy nasal spray to treat depression
Johnson & Johnson's Spravato has been approved to treat a major depressive disorder in adults who have had an inadequate response to at least two oral antidepressants, the FDA announced Tuesday.
Reuters25d
FDA approves standalone use of J&J's ketamine-derived depression treatment
Jan 21 (Reuters) - The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's (JNJ.N), opens new tab nasal spray, Spravato, to allow it to be used as a standalone treatment ...